Current therapy and advancements in the treatment of equine fungal keratitis.

This research article examines the treatment and advancements in managing equine fungal keratitis, an eye infection in horses. It suggests that improved diagnostic methods and new therapies offer potential improvements for detecting and treating this condition which affects many horses.

Equine Fungal Keratitis

• The research primarily focuses on equine fungal keratitis, an eye infection prevalent in horses. This condition constitutes a significant portion of all keratitis cases, as fungi involvement is noted in approximately half of all infectious cases in horses.
• Despite being a common occurrence, the research encourages more thorough retrospective analyses of this condition to better understand its patterns and effects.
• The outcomes of treating this condition are variable. In about two-thirds of the cases, there was complete healing with retained vision. In contrast, in some cases, enucleation, or the surgical removal of the eye, was necessary.

Common Pathogens and Resistance

• The primary pathogens associated with equine fungal keratitis include Aspergillus and Fusarium, with yeast being reported in less frequent instances.
• A significant obstacle in treating this condition is the resistance exhibited towards common antifungal agents from filamentous fungi, the type of fungi associated with Aspergillus and Fusarium infections.

Advancements in Diagnostics

• A crucial aspect of this research is to highlight the advancements in diagnostic methods which may improve the detection and treatment of equine fungal keratitis.
• These include repeat culture and antifungal susceptibility testing, which assess the effectiveness of different antifungal agents against the infectious fungi, aiding in strategic treatment decisions.
• Moreover, the integration of PCR technology, a method used to amplify copies of DNA segments, also shows promise in enhancing the detection of this condition.

New Treatment Modalities

• Newer antifungal treatments, the use of combination therapies, and innovative processes like photodynamic therapy present a potential for improved treatment outcomes.
• Photodynamic therapy involves using a photosensitive drug activated by a specific wavelength of light to destroy diseased cells.
• Despite the promising advancements, the research emphasizes the importance of continuous research efforts in understanding the epidemiology, pathogenesis, and optimal management strategies for this condition.